Literature DB >> 3503911

Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption.

S C Chang1, V H Lee.   

Abstract

The primary purpose of this study was to determine the relative contribution of the nasal and the conjunctival mucosae to the systemic absorption of topically applied timolol in the pigmented rabbit. The nasal mucosa was found to be about 2.5 times more efficient than the conjunctival mucosa in contributing to systemic timolol absorption, which occurred to the extent of 74% of the instilled dose. In addition, a minimum of 5-10 min prolongation of ocular contact time was determined to be necessary for significantly reducing systemic drug absorption and indirectly enhancing ocular drug absorption. The pharmaceutical implication of this finding is that ophthalmic vehicles such as polymeric inserts and gels would provide more favorable ocular to systemic drug absorption ratios than vehicles such as aqueous solutions and low-viscosity polymer solutions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3503911     DOI: 10.1089/jop.1987.3.159

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  11 in total

1.  Influence of format on in vitro penetration of antibody fragments through porcine cornea.

Authors:  H M Brereton; S D Taylor; A Farrall; D Hocking; M A Thiel; M Tea; D J Coster; K A Williams
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.

Authors:  P Ashton; S K Podder; V H Lee
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

3.  Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit.

Authors:  D S Chien; H Sasaki; H Bundgaard; A Buur; V H Lee
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

4.  Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits.

Authors:  D W Pate; K Järvinen; A Urtti; P Jarho; V Mahadevan; T Järvinen
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

5.  Lectins as endocytic ligands: an assessment of lectin binding and uptake to rabbit conjunctival epithelial cells.

Authors:  Mohamed Qaddoumi; Vincent H L Lee
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

6.  Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells.

Authors:  Veli-Pekka Ranta; Mirka Laavola; Elisa Toropainen; Kati-Sisko Vellonen; Anu Talvitie; Arto Urtti
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

7.  Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery.

Authors:  L Marchal-Heussler; D Sirbat; M Hoffman; P Maincent
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

8.  Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops.

Authors:  Khaled Abduljalil; Michael Diestelhorst; Oxana Doroshyenko; Anja Lux; Andre Steinfeld; Sven Dinslage; Richard Süverkrüp; Uwe Fuhr
Journal:  Eur J Clin Pharmacol       Date:  2008-01-25       Impact factor: 2.953

9.  Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.

Authors:  A Urtti; H Rouhiainen; T Kaila; V Saano
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

10.  Partitioning and Spatial Distribution of Drugs in Ocular Surface Tissues.

Authors:  Anusha Balla; Seppo Auriola; Angus C Grey; Nicholas J Demarais; Annika Valtari; Emma M Heikkinen; Elisa Toropainen; Arto Urtti; Kati-Sisko Vellonen; Marika Ruponen
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.